RISK FACTORS FOR BREAKTHROUGH COVID-19 IN 14,713 UK ADULTS AFTER PRIMARY AND BOOSTER DOSES OF SARS-COV-2 VACCINES
dc.contributor.author | Vivaldi, G | en_US |
dc.contributor.author | Jolliffe, DA | en_US |
dc.contributor.author | Holt, H | en_US |
dc.contributor.author | Talaei, M | en_US |
dc.contributor.author | Tydeman, F | en_US |
dc.contributor.author | Shaheen, SO | en_US |
dc.contributor.author | Martineau, AR | en_US |
dc.date.accessioned | 2023-03-23T10:58:32Z | |
dc.date.issued | 2022 | en_US |
dc.identifier.issn | 0040-6376 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/85201 | |
dc.format.extent | A25 - A26 | en_US |
dc.title | RISK FACTORS FOR BREAKTHROUGH COVID-19 IN 14,713 UK ADULTS AFTER PRIMARY AND BOOSTER DOSES OF SARS-COV-2 VACCINES | en_US |
dc.type | Conference Proceeding | |
dc.identifier.doi | 10.1136/thorax-2022-BTSabstracts.43 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000920272300044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 77 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Centre for Immunobiology [1121]